(Q35607794)

9 August 2017

title

Tenofovir versus entecavir in treatment of chronic hepatitis B virus with severe acute exacerbation (English)

1 reference

9 August 2017

1 reference

1 reference

1 reference

1 reference

1 reference

Chao-Hung Hung

1

1 reference

9 August 2017

Tsung-Hui Hu

2

1 reference

9 August 2017

Sheng-Nan Lu

3

1 reference

9 August 2017

Chuan-Mo Lee

4

1 reference

9 August 2017

Chih-Hung Chen

5

1 reference

9 August 2017

Kwong-Ming Kee

6

1 reference

9 August 2017

Jing-Houng Wang

7

1 reference

9 August 2017

Ming-Chao Tsai

8

1 reference

9 August 2017

Yuan-Hung Kuo

9

1 reference

9 August 2017

Kuo-Chin Chang

10

1 reference

9 August 2017

Yi-Chun Chiu

11

1 reference

9 August 2017

Chien-Hung Chen

12

1 reference

9 August 2017

language of work or name

English

0 references

publication date

16 March 2015

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

59

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

3168-3173

1 reference

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Comparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Comparison of tenofovir and entecavir in patients with chronic HBV infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Management of acute hepatitis B and reactivation of hepatitis B.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Chronic hepatitis B: update 2009

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Acute kidney injury in acute liver failure: a review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Precore/core promoter mutations and hepatitis B virus genotype in hepatitis B and C dually infected patients treated with interferon-based therapy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Tenofovir disoproxil fumarate: role in hepatitis B treatment

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4432180

Hepatitis B virus infection

25 September 2018

1 reference

12 December 2020

Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure

1 reference

12 December 2020

Entecavir versus lamivudine in the treatment of chronic hepatitis B patients with hepatic decompensation

1 reference

12 December 2020

Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B

1 reference

12 December 2020

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

1 reference

12 December 2020

Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure

1 reference

12 December 2020

Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B

1 reference

12 December 2020

Long-term lamivudine treatment is associated with a good maintained response in severe acute exacerbation of chronic HBeAg-negative hepatitis B

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00261-15

1 reference

9 August 2017

1 reference

9 August 2017

1 reference